PROREPAIR-B is an ongoing prospective study to evaluate the outcomes of patients with metastatic castrate-resistant prostate cancer with and without germline ATM/BRCA1/BRCA2/PALB2 mutations46. The gene discussed is ATM; the disease is prostate cancer.